Lacy Katzen attorneys and support professionals remind you that we are here to help!  We remain committed to providing uninterrupted excellent client service during the Covid-19 crisis as we continue to do our part in protecting the health and well-being of our co-workers, family members and our community.  Read More
You are currently using Internet Explorer to browse our website. This website is best viewed by utilizing an alternate web browser as some features may not be visible.
HOME|CAREERS|ABOUT585.454.5650Search Icon
image of roundup weedkiller bottles.
In Late June of 2020, the pharmaceutical giant Bayer agreed to pay over $10 billion to settle thousands of cancer claims against Roundup™, a popular weedkiller brand produced by its agrochemical company; Monsanto. In 2018, Bayer acquired Monsanto as part of its crop science division, making Bayer the parent company of the troubled manufacturer of the weedkiller.

With Bayer’s acquisition of Monsanto came widespread claims that a deadly link to cancer was associated with the weedkiller. Allegations have focused on Roundup’s active ingredient, glyphosate. In 2015, the World Health Organization’s International Agency for Research on Cancer labeled glyphosate as a “probable carcinogenic to humans.” Despite this, Monsanto and Bayer have long insisted that glyphosate poses no risk to humans. Thousands of lawsuits from plaintiffs across the country assert that Roundup formula has caused non-Hodgkin’s lymphoma, a type of lymphatic cancer.

Bayer proposed to use $8.8 to $9.6 billion to settle 75% of the more than 100,000 existing claims with another $1.25 billion to be set aside to resolve “potential future litigation.” Under the proposal, a portion of the $1.25 billion would be allocated to the creation of an independent expert panel that would review the threshold of glyphosate exposure relative to cancer risks. If the panel finds definitive links to cancer, the pharmaceutical giant will not be able to argue against these findings in future cases. However, in early July Bayer backed away from this portion of the plan after a federal judge made it clear he would not approve the plan stating he was skeptical of its fairness. Even as the company offers up billions to settle cases, Bayer CEO Werner Baumann, still claims that its glyphosate-based herbicides are safe. He stated that the settlement is meant to end “long period of uncertainty for the company.” He went on to say, “At the same time, the extensive body of science indicates that Roundup™ does not cause cancer, and therefore, is not responsible for the illnesses alleged in this litigation. We stand strongly behind our glyphosate-based herbicides, which are among the most rigorously studied products of their kind, and four decades of science support their safety and that they are not carcinogenic.”

If you believe that you have cancer due to Roundup usage, please contact attorney Jacqueline Thomas for a free consultation. It is important that you act promptly as time may be limited to pursue a claim.

Written by Jacqueline Thomas, Esq.
Share This Posting
Best Lawyers Badge
Home About OfficesFAQs Careers Recent Articles
Lacy Katzen LLP Attorneys at Law.
Site designed & developed by Scriptable Solutions.

Client Rights | Accessibility | Contact Us
Lacy Katze, LLP Logo in White

Main Office
Lacy Katzen Law Firm
600 Bausch & Lomb Place
Rochester, NY 14604

Open Monday - Friday
8:00am - 4:00pm
Facebook icon
LinkedIn icon
The "New York State Rules of Professional Conduct" establishes various criteria governing attorney advertising and solicitation. Pursuant to these rules, portions of this website may be considered ATTORNEY ADVERTISING.